Coronary Syndrome
📧 Sign up to get email alerts when something new happens for Coronary Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Tanhuo Decoction for Acute Coronary Syndrome With Cerebral Atherosclerosis in Elderly Patients [NA]
Registration for a study evaluating Tanhuo Decoction in elderly patients with acute coronary syndrome and cerebral atherosclerosis; the tria…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Prospective, Single-center, Observational Study Aiming to Assess the Predictive Role of Flow Mediated Dilatation in Acute Coronary Syndromes, Combined With Echocardiographic and Biochemical Indices
This clinical trial update outlines a prospective, single-center observational study to evaluate whether flow-mediated dilatation (FMD), alo…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Drug-Coated Balloon Primary PCI in ST-Segment Elevation Myocardial Infarction
An update indicating that a clinical trial evaluating the use of a drug-coated balloon during primary PCI for ST-segment elevation myocardia…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: triPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE [Phase 3]
Phase 3 trial evaluating triPle oral therapy including bempedoic acid for early lipid management in patients with acute coronary syndrome; t…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Association Between SYNTAX Score and Leukoglycemic Index In Patients Wiht Acute Coronary Syndrome
This clinical trial update reports on the association between SYNTAX score and leukoglycemic index in patients with acute coronary syndrome.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Optimal Antiplatelet and Lipid Therapy in ACS With DES: OPACT Trial [NA]
Clinical trial update for the OPACT trial evaluating optimal antiplatelet and lipid therapy in acute coronary syndrome treated with drug-elu…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Placebo-controlled Study of Single and Multiple Ascending Doses of UDP-003 in Healthy Human Participants and Patients [EARLY_Phase 1]
Early-phase, placebo-controlled study to evaluate single and multiple ascending doses of UDP-003 in healthy participants and patients with a…
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: Telemedicine in High-Risk Cardiovascular Patients Post-ACS [NA]
A completed clinical trial from Imperial College London evaluated telemedicine for high-risk cardiovascular patients after acute coronary sy…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Development and Validation of Care Pathway Quality Indicators for Stroke and Chronic Coronary Syndrome Using French Administrative Healthcare Database (DELIQUA-CNV)
This completed study describes the development and validation of quality indicators for care pathways in stroke and chronic coronary syndrom…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Revascularization Strategies in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) and Severe Coronary Artery Disease [NA]
This entry describes an ongoing clinical trial comparing revascularization strategies for patients with non-ST-segment elevation acute coron…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Educational Video to Improve Understanding and Reduce Anxiety in Heart Attack Patients [NA]
This clinical trial evaluates an educational video designed to improve understanding and reduce anxiety in patients with acute coronary synd…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: ARCANGELO (itAlian pRospective Study on CANGrELOr)
ARCANGELO is an Italian prospective study evaluating canagrelor for acute coronary syndrome; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes? [Phase 4]
Phase 4 trial evaluating whether lowering the aspirin dose improves outcomes when added to rivaroxaban in chronic coronary syndrome patients…
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: OptimiZation Of Lipid Lowering Therapies Using a Decision Support System In Patients With Acute Coronary Syndrome. [NA]
A completed study evaluating a decision-support system to optimize lipid-lowering therapy in patients with Acute Coronary Syndrome and Myoca…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study [Phase 4]
Phase 4 prospective multicenter study MACT evaluating mono antiplatelet therapy with colchicine in acute coronary syndrome is currently recr…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Assessment of GARP Expression in Acute and Chronic Coronary Syndrome [NA]
Clinical trial update describing a study assessing GARP expression in acute and chronic coronary syndrome, which is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Gut Microbiota Modulation With Synbiotics After Acute Coronary Syndrome [NA]
Clinical trial evaluating gut microbiota modulation with synbiotics after acute coronary syndrome; currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Efficacy and Safety of GENOSS® SES in Patients With Acute Coronary Syndrome (GENOSS ACS)
This clinical trial update evaluates the efficacy and safety of GENOSS SES in patients with acute coronary syndrome undergoing percutaneous …
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Parenteral Antiplatelet Agents in Real-world Spanish PCI Patients
A clinical trial by Fundación EPIC evaluating parenteral antiplatelet agents in real-world Spanish PCI patients; the study is currently acti…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Enabling Patient-Reported Outcomes Through Innovative Care - ACS (EPIC-ACS) [NA]
A Mahidol University-led clinical trial (EPIC-ACS) aims to enable patient-reported outcomes in acute coronary syndrome and coronary artery d…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Metabolic Characteristics and Prognostic Model of Acute Coronary Syndrome Complicated With Obstructive Sleep Apnea
The clinical trial studies metabolic characteristics and a prognostic model for acute coronary syndrome complicated by obstructive sleep apn…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
A completed clinical trial evaluating outcomes of the Xience Sierra everolimus-eluting stent in complex all-comer patients, including those …
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Reversal to Normoglycemia by Treating Prediabetes [Phase 3]
A Phase 3 clinical trial is investigating reversing to normoglycemia by treating prediabetes; the study is currently not yet recruiting.
-
FDA approval · 2026-02-06FDA Approved: TICAGRELOR — Original Application (Lifestar Pharma LLC)
The FDA approved Lifestar Pharma LLC's original ANDA for ticagrelor, a P2Y12 receptor inhibitor used to reduce thrombotic cardiovascular eve…
-
EMA approval · 2026-02-05EMA Authorised: Clopidogrel Zentiva (previously Clopidogrel Winthrop) (clopidogrel) — Zentiva k.s.
The European Medicines Agency authorised Zentiva’s generic clopidogrel product for prevention of stroke, myocardial infarction, acute corona…